Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $6.92 million. The enterprise value is $3.63 million.
Market Cap | 6.92M |
Enterprise Value | 3.63M |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ADIL has 6.40 million shares outstanding. The number of shares has increased by 145.84% in one year.
Shares Outstanding | 6.40M |
Shares Change (YoY) | +145.84% |
Shares Change (QoQ) | +41.60% |
Owned by Insiders (%) | 1.57% |
Owned by Institutions (%) | 4.62% |
Float | 6.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.08 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69
Current Ratio | 5.69 |
Quick Ratio | 4.89 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -320.96% and return on invested capital (ROIC) is -119.73%.
Return on Equity (ROE) | -320.96% |
Return on Assets (ROA) | -104.18% |
Return on Capital (ROIC) | -119.73% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.75M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.43% in the last 52 weeks. The beta is 1.30, so ADIL's price volatility has been higher than the market average.
Beta (5Y) | 1.30 |
52-Week Price Change | -61.43% |
50-Day Moving Average | 1.04 |
200-Day Moving Average | 1.41 |
Relative Strength Index (RSI) | 55.93 |
Average Volume (20 Days) | 134,978 |
Short Selling Information
The latest short interest is 272,781, so 4.26% of the outstanding shares have been sold short.
Short Interest | 272,781 |
Short Previous Month | 318,891 |
Short % of Shares Out | 4.26% |
Short % of Float | 4.34% |
Short Ratio (days to cover) | 0.94 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.27M |
Pretax Income | -8.69M |
Net Income | -12.24M |
EBITDA | -7.27M |
EBIT | -7.27M |
Earnings Per Share (EPS) | -$4.60 |
Balance Sheet
Cash & Cash Equivalents | 3.29M |
Total Debt | n/a |
Net Cash | 3.29M |
Net Cash Per Share | $0.51 |
Equity (Book Value) | 4.28M |
Book Value Per Share | 1.00 |
Working Capital | 3.15M |
Cash Flow
Operating Cash Flow | -6.39M |
Capital Expenditures | n/a |
Free Cash Flow | -6.39M |
FCF Per Share | -$1.00 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -145.84% |
Shareholder Yield | -145.84% |
Earnings Yield | -176.99% |
FCF Yield | -92.37% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -49.14% |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Aug 7, 2023 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |